Gallo E - Search Results

1

Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics.

London M, Gallo E. London M, et al. Among authors: gallo e. Mol Biol Rep. 2020 Jul;47(7):5523-5533. doi: 10.1007/s11033-020-05571-8. Epub 2020 Jul 3. Mol Biol Rep. 2020. PMID: 32621117 Review.

2

Epidermal growth factor receptor (EGFR) involvement in epithelial-derived cancers and its current antibody-based immunotherapies.

London M, Gallo E. London M, et al. Among authors: gallo e. Cell Biol Int. 2020 Jun;44(6):1267-1282. doi: 10.1002/cbin.11340. Epub 2020 Mar 17. Cell Biol Int. 2020. PMID: 32162758 Review.

3

The EphA2 and cancer connection: potential for immune-based interventions.

London M, Gallo E. London M, et al. Among authors: gallo e. Mol Biol Rep. 2020 Oct;47(10):8037-8048. doi: 10.1007/s11033-020-05767-y. Epub 2020 Sep 29. Mol Biol Rep. 2020. PMID: 32990903 Review.

4

Inhibition of Cancer Cell Adhesion, Migration and Proliferation by a Bispecific Antibody that Targets two Distinct Epitopes on αv Integrins.

Gallo E, Kelil A, Haughey M, Cazares-Olivera M, Yates BP, Zhang M, Wang NY, Blazer L, Carderelli L, Adams JJ, Kossiakoff AA, Wells JA, Xie W, Sidhu SS. Gallo E, et al. J Mol Biol. 2021 Jul 23;433(15):167090. doi: 10.1016/j.jmb.2021.167090. Epub 2021 Jun 4. J Mol Biol. 2021. PMID: 34090922

5

Current advancements in B-cell receptor sequencing fast-track the development of synthetic antibodies.

Gallo E. Gallo E. Mol Biol Rep. 2024 Jan 18;51(1):134. doi: 10.1007/s11033-023-08941-0. Mol Biol Rep. 2024. PMID: 38236361 Review.

6

High-Throughput Generation of In Silico Derived Synthetic Antibodies via One-step Enzymatic DNA Assembly of Fragments.

Gallo E. Gallo E. Mol Biotechnol. 2020 Feb;62(2):142-150. doi: 10.1007/s12033-019-00232-z. Mol Biotechnol. 2020. PMID: 31894513

7

A High-Throughput Platform for the Generation of Synthetic Ab Clones by Single-Strand Site-Directed Mutagenesis.

Gallo E. Gallo E. Mol Biotechnol. 2019 Jun;61(6):410-420. doi: 10.1007/s12033-019-00171-9. Mol Biotechnol. 2019. PMID: 30963479

8

Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances.

Gallo E. Gallo E. Mol Biotechnol. 2024 Feb 3. doi: 10.1007/s12033-024-01064-2. Online ahead of print. Mol Biotechnol. 2024. PMID: 38308755 Review.

9

CellectSeq: In silico discovery of antibodies targeting integral membrane proteins combining in situ selections and next-generation sequencing.

Kelil A, Gallo E, Banerjee S, Adams JJ, Sidhu SS. Kelil A, et al. Among authors: gallo e. Commun Biol. 2021 May 12;4(1):561. doi: 10.1038/s42003-021-02066-5. Commun Biol. 2021. PMID: 33980972 Free PMC article.

10

USP10 Promotes Fibronectin Recycling, Secretion, and Organization.

Phillips AT, Boumil EF, Castro N, Venkatesan A, Gallo E, Adams JJ, Sidhu SS, Bernstein AM. Phillips AT, et al. Among authors: gallo e. Invest Ophthalmol Vis Sci. 2021 Oct 4;62(13):15. doi: 10.1167/iovs.62.13.15. Invest Ophthalmol Vis Sci. 2021. PMID: 34665194 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

927 results

Search Page

Filters